Difference between revisions of "The Regents of the University of California patent applications published on November 30th, 2023"

From WikiPatents
Jump to navigation Jump to search
(Creating a new page)
Line 1: Line 1:
−
'''Summary of the patent applications from The Regents of the University of California on November 30th, 2023'''
 
−
 
−
The Regents of the University of California have recently filed several patents for various innovative technologies. These patents cover a range of fields, including quantum communication, biosensors, reactive oxygen species detection, leaf wetness sensing, particle imaging and sorting, solar energy collection, adaptive reciprocating engines, catalyst compositions, and mental disorder diagnosis.
 
−
 
−
In the field of quantum communication, the organization has developed a system and method for transmitting quantum datagrams over a network. This technology separates the classical non-quantum optical bits from the quantum data payload, allowing for the transportation of quantum datagrams while preserving the integrity of the quantum data payload.
 
−
 
−
The organization has also invented fluorescent biosensors for detecting and measuring the effects of hallucinogenic and antidepressant compounds. These biosensors can detect ligand-induced hallucinogenic conformational changes in G Protein-Coupled Receptors (GPCRs) and can be used to measure the hallucinogenic and antipsychotic potential of compounds.
 
−
 
−
Another patent application describes a method for detecting and labeling reactive oxygen species (ROS) using selective probes. This approach allows for simultaneous sensing and labeling of ROS, providing a simplified and efficient way to detect and label these species, which can be useful in biomedical research and diagnostics.
 
−
 
−
The organization has also developed a biomimetic leaf wetness sensor that accurately detects the wetness of leaves by mimicking the interaction between a real leaf and moisture. This sensor can find applications in agriculture, plant research, and environmental monitoring.
 
−
 
−
In the field of particle imaging and sorting, the organization has created a system for real-time imaging and sorting of particles, particularly cells, in a flow system. This technology can be used in flow cytometry applications for cell analysis and sorting based on specific properties.
 
−
 
−
The organization has also filed a patent for a solar collector that uses a wide-angle, nonimaging asymmetric optical reflector to collect solar energy. This collector can generate high-quality steam for solar industrial process heat applications.
 
−
 
−
In the field of engines, the organization has developed an adaptive reciprocating engine that can adjust its operation based on sensor feedback, allowing for optimized performance and efficiency across a range of operating conditions.
 
−
 
−
A catalyst composition consisting of graphitic carbon nitride and platinum oxide nanoparticles has also been patented. This composition offers improved performance and efficiency compared to existing catalyst compositions and can be used in fuel cells, chemical synthesis, and environmental remediation.
 
−
 
−
Lastly, the organization has invented a method for diagnosing and differentiating bipolar disorder and schizophrenia using specific combinations of biomarkers. This method provides more accurate and reliable diagnoses, leading to better treatment options for patients.
 
−
 
−
Notable applications of these technologies include quantum communication networks, detection and measurement of hallucinogenic and antidepressant compounds, improved understanding and detection of ROS-related diseases, realistic measurement of leaf wetness, advanced particle imaging and sorting in flow cytometry, efficient solar energy collection for industrial processes, optimized reciprocating engines, enhanced catalytic reactions, and improved diagnosis and treatment of bipolar disorder and schizophrenia.
 
−
 
−
 
−
 
−
 
 
==Patent applications for The Regents of the University of California on November 30th, 2023==
 
==Patent applications for The Regents of the University of California on November 30th, 2023==
  
−
===METHODS FOR NON-INVASIVE, LABEL-FREE IMAGING OF CELLULAR IMMUNE RESPONSE IN HUMAN SKIN USING A NONLINEAR OPTICAL MICROSCOPY IMAGING SYSTEM ([[US Patent Application 18202874. METHODS FOR NON-INVASIVE, LABEL-FREE IMAGING OF CELLULAR IMMUNE RESPONSE IN HUMAN SKIN USING A NONLINEAR OPTICAL MICROSCOPY IMAGING SYSTEM simplified abstract|18202874]])===
+
===METHODS FOR NON-INVASIVE, LABEL-FREE IMAGING OF CELLULAR IMMUNE RESPONSE IN HUMAN SKIN USING A NONLINEAR OPTICAL MICROSCOPY IMAGING SYSTEM ([[US Patent Application 18202874. METHODS FOR NON-INVASIVE, LABEL-FREE IMAGING OF CELLULAR IMMUNE RESPONSE IN HUMAN SKIN USING A NONLINEAR OPTICAL MICROSCOPY IMAGING SYSTEM simplified abstract (The Regents of the University of California)|18202874]])===
  
  
Line 36: Line 9:
  
  
−
===COMPOSITIONS AND METHODS FOR AMELIORATING MEDICAL CONDITIONS ([[US Patent Application 18028311. COMPOSITIONS AND METHODS FOR AMELIORATING MEDICAL CONDITIONS simplified abstract|18028311]])===
+
===COMPOSITIONS AND METHODS FOR AMELIORATING MEDICAL CONDITIONS ([[US Patent Application 18028311. COMPOSITIONS AND METHODS FOR AMELIORATING MEDICAL CONDITIONS simplified abstract (The Regents of the University of California)|18028311]])===
  
  
Line 44: Line 17:
  
  
−
===CONJOINT THERAPIES FOR TREATING VIRAL INFECTIONS ([[US Patent Application 18178266. CONJOINT THERAPIES FOR TREATING VIRAL INFECTIONS simplified abstract|18178266]])===
+
===CONJOINT THERAPIES FOR TREATING VIRAL INFECTIONS ([[US Patent Application 18178266. CONJOINT THERAPIES FOR TREATING VIRAL INFECTIONS simplified abstract (The Regents of the University of California)|18178266]])===
  
  
Line 52: Line 25:
  
  
−
===ANTI-DPP6 CHIMERIC ANTIGEN RECEPTOR BEARING REGULATORY T CELLS ([[US Patent Application 18034037. ANTI-DPP6 CHIMERIC ANTIGEN RECEPTOR BEARING REGULATORY T CELLS simplified abstract|18034037]])===
+
===ANTI-DPP6 CHIMERIC ANTIGEN RECEPTOR BEARING REGULATORY T CELLS ([[US Patent Application 18034037. ANTI-DPP6 CHIMERIC ANTIGEN RECEPTOR BEARING REGULATORY T CELLS simplified abstract (The Regents of the University of California)|18034037]])===
  
  
Line 60: Line 33:
  
  
−
===ATTENUATED CANCER CELLS AND METHODS RELATED THERETO ([[US Patent Application 18032932. ATTENUATED CANCER CELLS AND METHODS RELATED THERETO simplified abstract|18032932]])===
+
===ATTENUATED CANCER CELLS AND METHODS RELATED THERETO ([[US Patent Application 18032932. ATTENUATED CANCER CELLS AND METHODS RELATED THERETO simplified abstract (The Regents of the University of California)|18032932]])===
  
  
Line 68: Line 41:
  
  
−
===MICROFLUDIC LAB-ON-CHIP DEVICE, MATRIX, SMALL MOLECULES AND THREE-DIMENSIONAL SPHEROIDS FOR CELL REPROGRAMMING ([[US Patent Application 18315370. MICROFLUDIC LAB-ON-CHIP DEVICE, MATRIX, SMALL MOLECULES AND THREE-DIMENSIONAL SPHEROIDS FOR CELL REPROGRAMMING simplified abstract|18315370]])===
+
===MICROFLUDIC LAB-ON-CHIP DEVICE, MATRIX, SMALL MOLECULES AND THREE-DIMENSIONAL SPHEROIDS FOR CELL REPROGRAMMING ([[US Patent Application 18315370. MICROFLUDIC LAB-ON-CHIP DEVICE, MATRIX, SMALL MOLECULES AND THREE-DIMENSIONAL SPHEROIDS FOR CELL REPROGRAMMING simplified abstract (The Regents of the University of California)|18315370]])===
  
  
Line 76: Line 49:
  
  
−
===APPARATUS AND METHODS FOR METHYL MERCURY DETECTION AND CAPTURE ([[US Patent Application 18311630. APPARATUS AND METHODS FOR METHYL MERCURY DETECTION AND CAPTURE simplified abstract|18311630]])===
+
===APPARATUS AND METHODS FOR METHYL MERCURY DETECTION AND CAPTURE ([[US Patent Application 18311630. APPARATUS AND METHODS FOR METHYL MERCURY DETECTION AND CAPTURE simplified abstract (The Regents of the University of California)|18311630]])===
  
  
Line 84: Line 57:
  
  
−
===TRANSCRIPTION ACTIVE COMPLEX TARGETING CANCER DRUG FROM VIRAL PROTEIN SEQUENCE ([[US Patent Application 18248291. TRANSCRIPTION ACTIVE COMPLEX TARGETING CANCER DRUG FROM VIRAL PROTEIN SEQUENCE simplified abstract|18248291]])===
+
===TRANSCRIPTION ACTIVE COMPLEX TARGETING CANCER DRUG FROM VIRAL PROTEIN SEQUENCE ([[US Patent Application 18248291. TRANSCRIPTION ACTIVE COMPLEX TARGETING CANCER DRUG FROM VIRAL PROTEIN SEQUENCE simplified abstract (The Regents of the University of California)|18248291]])===
  
  
Line 92: Line 65:
  
  
−
===MULTIMERIC PROTEIN COMPLEXES AS ANTIBODY SUBSTITUTES FOR NEUTRALIZATION OF VIRAL PATHOGENS IN PROPHYLACTIC AND THERAPEUTIC APPLICATIONS ([[US Patent Application 18028345. MULTIMERIC PROTEIN COMPLEXES AS ANTIBODY SUBSTITUTES FOR NEUTRALIZATION OF VIRAL PATHOGENS IN PROPHYLACTIC AND THERAPEUTIC APPLICATIONS simplified abstract|18028345]])===
+
===MULTIMERIC PROTEIN COMPLEXES AS ANTIBODY SUBSTITUTES FOR NEUTRALIZATION OF VIRAL PATHOGENS IN PROPHYLACTIC AND THERAPEUTIC APPLICATIONS ([[US Patent Application 18028345. MULTIMERIC PROTEIN COMPLEXES AS ANTIBODY SUBSTITUTES FOR NEUTRALIZATION OF VIRAL PATHOGENS IN PROPHYLACTIC AND THERAPEUTIC APPLICATIONS simplified abstract (The Regents of the University of California)|18028345]])===
  
  
Line 100: Line 73:
  
  
−
===ANTI-CD46 ANTIBODIES AND METHODS OF USE ([[US Patent Application 17815514. ANTI-CD46 ANTIBODIES AND METHODS OF USE simplified abstract|17815514]])===
+
===ANTI-CD46 ANTIBODIES AND METHODS OF USE ([[US Patent Application 17815514. ANTI-CD46 ANTIBODIES AND METHODS OF USE simplified abstract (The Regents of the University of California)|17815514]])===
  
  
Line 108: Line 81:
  
  
−
===MAGNETICALLY TUNABLE PLASMON COUPLING OF NANOSHELLS ENABLED BY SPACE-FREE CONFINED GROWTH ([[US Patent Application 18247960. MAGNETICALLY TUNABLE PLASMON COUPLING OF NANOSHELLS ENABLED BY SPACE-FREE CONFINED GROWTH simplified abstract|18247960]])===
+
===MAGNETICALLY TUNABLE PLASMON COUPLING OF NANOSHELLS ENABLED BY SPACE-FREE CONFINED GROWTH ([[US Patent Application 18247960. MAGNETICALLY TUNABLE PLASMON COUPLING OF NANOSHELLS ENABLED BY SPACE-FREE CONFINED GROWTH simplified abstract (The Regents of the University of California)|18247960]])===
  
  
Line 116: Line 89:
  
  
−
===BIOMARKERS FOR BIPOLAR DISORDER AND SCHIZOPHRENIA ([[US Patent Application 18333231. BIOMARKERS FOR BIPOLAR DISORDER AND SCHIZOPHRENIA simplified abstract|18333231]])===
+
===BIOMARKERS FOR BIPOLAR DISORDER AND SCHIZOPHRENIA ([[US Patent Application 18333231. BIOMARKERS FOR BIPOLAR DISORDER AND SCHIZOPHRENIA simplified abstract (The Regents of the University of California)|18333231]])===
  
  
Line 124: Line 97:
  
  
−
===PLATINUM OXIDE NANOPARTICLES FOR ELECTROCHEMICAL HYDROGEN EVOLUTION AND METHODS FOR MAKING AND USING THE SAME ([[US Patent Application 18449110. PLATINUM OXIDE NANOPARTICLES FOR ELECTROCHEMICAL HYDROGEN EVOLUTION AND METHODS FOR MAKING AND USING THE SAME simplified abstract|18449110]])===
+
===PLATINUM OXIDE NANOPARTICLES FOR ELECTROCHEMICAL HYDROGEN EVOLUTION AND METHODS FOR MAKING AND USING THE SAME ([[US Patent Application 18449110. PLATINUM OXIDE NANOPARTICLES FOR ELECTROCHEMICAL HYDROGEN EVOLUTION AND METHODS FOR MAKING AND USING THE SAME simplified abstract (The Regents of the University of California)|18449110]])===
  
  
Line 132: Line 105:
  
  
−
===ADAPTIVE ANY-FUEL CAMLESS RECIPROCATING ENGINE ([[US Patent Application 18301825. ADAPTIVE ANY-FUEL CAMLESS RECIPROCATING ENGINE simplified abstract|18301825]])===
+
===ADAPTIVE ANY-FUEL CAMLESS RECIPROCATING ENGINE ([[US Patent Application 18301825. ADAPTIVE ANY-FUEL CAMLESS RECIPROCATING ENGINE simplified abstract (The Regents of the University of California)|18301825]])===
  
  
Line 140: Line 113:
  
  
−
===NONIMAGING ASYMMETRIC SHADELESS COLLECTOR ([[US Patent Application 18030729. NONIMAGING ASYMMETRIC SHADELESS COLLECTOR simplified abstract|18030729]])===
+
===NONIMAGING ASYMMETRIC SHADELESS COLLECTOR ([[US Patent Application 18030729. NONIMAGING ASYMMETRIC SHADELESS COLLECTOR simplified abstract (The Regents of the University of California)|18030729]])===
  
  
Line 148: Line 121:
  
  
−
===IMAGE-BASED CELL SORTING SYSTEMS AND METHODS ([[US Patent Application 18295244. IMAGE-BASED CELL SORTING SYSTEMS AND METHODS simplified abstract|18295244]])===
+
===IMAGE-BASED CELL SORTING SYSTEMS AND METHODS ([[US Patent Application 18295244. IMAGE-BASED CELL SORTING SYSTEMS AND METHODS simplified abstract (The Regents of the University of California)|18295244]])===
  
  
Line 156: Line 129:
  
  
−
===BIOMIMETIC LEAF WETNESS SENSOR AND METHOD OF MANUFACTURE OF THE SAME ([[US Patent Application 18201886. BIOMIMETIC LEAF WETNESS SENSOR AND METHOD OF MANUFACTURE OF THE SAME simplified abstract|18201886]])===
+
===BIOMIMETIC LEAF WETNESS SENSOR AND METHOD OF MANUFACTURE OF THE SAME ([[US Patent Application 18201886. BIOMIMETIC LEAF WETNESS SENSOR AND METHOD OF MANUFACTURE OF THE SAME simplified abstract (The Regents of the University of California)|18201886]])===
  
  
Line 164: Line 137:
  
  
−
===Tandem Activity-Based Sensing and Labeling Strategy for Reactive Oxygen Species Imaging ([[US Patent Application 18363714. Tandem Activity-Based Sensing and Labeling Strategy for Reactive Oxygen Species Imaging simplified abstract|18363714]])===
+
===Tandem Activity-Based Sensing and Labeling Strategy for Reactive Oxygen Species Imaging ([[US Patent Application 18363714. Tandem Activity-Based Sensing and Labeling Strategy for Reactive Oxygen Species Imaging simplified abstract (The Regents of the University of California)|18363714]])===
  
  
Line 172: Line 145:
  
  
−
===GPCR SCREENING METHOD TO IDENTIFY NON-HALLUCINOGENIC COMPOUNDS ([[US Patent Application 18248934. GPCR SCREENING METHOD TO IDENTIFY NON-HALLUCINOGENIC COMPOUNDS simplified abstract|18248934]])===
+
===GPCR SCREENING METHOD TO IDENTIFY NON-HALLUCINOGENIC COMPOUNDS ([[US Patent Application 18248934. GPCR SCREENING METHOD TO IDENTIFY NON-HALLUCINOGENIC COMPOUNDS simplified abstract (The Regents of the University of California)|18248934]])===
  
  
Line 180: Line 153:
  
  
−
===QUANTUM WRAPPER NETWORKING ([[US Patent Application 18248931. QUANTUM WRAPPER NETWORKING simplified abstract|18248931]])===
+
===QUANTUM WRAPPER NETWORKING ([[US Patent Application 18248931. QUANTUM WRAPPER NETWORKING simplified abstract (The Regents of the University of California)|18248931]])===
  
  

Revision as of 07:05, 5 December 2023

Contents

Patent applications for The Regents of the University of California on November 30th, 2023

METHODS FOR NON-INVASIVE, LABEL-FREE IMAGING OF CELLULAR IMMUNE RESPONSE IN HUMAN SKIN USING A NONLINEAR OPTICAL MICROSCOPY IMAGING SYSTEM (18202874)

Main Inventor

Mihaela Balu


COMPOSITIONS AND METHODS FOR AMELIORATING MEDICAL CONDITIONS (18028311)

Main Inventor

Daniel L. KAUFMAN


CONJOINT THERAPIES FOR TREATING VIRAL INFECTIONS (18178266)

Main Inventor

Varghese John


ANTI-DPP6 CHIMERIC ANTIGEN RECEPTOR BEARING REGULATORY T CELLS (18034037)

Main Inventor

Qizhi TANG


ATTENUATED CANCER CELLS AND METHODS RELATED THERETO (18032932)

Main Inventor

Zhen Gu


MICROFLUDIC LAB-ON-CHIP DEVICE, MATRIX, SMALL MOLECULES AND THREE-DIMENSIONAL SPHEROIDS FOR CELL REPROGRAMMING (18315370)

Main Inventor

Song Li


APPARATUS AND METHODS FOR METHYL MERCURY DETECTION AND CAPTURE (18311630)

Main Inventor

Jennifer Lu


TRANSCRIPTION ACTIVE COMPLEX TARGETING CANCER DRUG FROM VIRAL PROTEIN SEQUENCE (18248291)

Main Inventor

Yoshihiro Izumiya


MULTIMERIC PROTEIN COMPLEXES AS ANTIBODY SUBSTITUTES FOR NEUTRALIZATION OF VIRAL PATHOGENS IN PROPHYLACTIC AND THERAPEUTIC APPLICATIONS (18028345)

Main Inventor

Daniel L. COX


ANTI-CD46 ANTIBODIES AND METHODS OF USE (17815514)

Main Inventor

Bin Liu


MAGNETICALLY TUNABLE PLASMON COUPLING OF NANOSHELLS ENABLED BY SPACE-FREE CONFINED GROWTH (18247960)

Main Inventor

Yadong Yin


BIOMARKERS FOR BIPOLAR DISORDER AND SCHIZOPHRENIA (18333231)

Main Inventor

Terry W. Osborn


PLATINUM OXIDE NANOPARTICLES FOR ELECTROCHEMICAL HYDROGEN EVOLUTION AND METHODS FOR MAKING AND USING THE SAME (18449110)

Main Inventor

Shaowei Chen


ADAPTIVE ANY-FUEL CAMLESS RECIPROCATING ENGINE (18301825)

Main Inventor

Raymond Mitchell Spearrin


NONIMAGING ASYMMETRIC SHADELESS COLLECTOR (18030729)

Main Inventor

Bennett WIDYOLAR


IMAGE-BASED CELL SORTING SYSTEMS AND METHODS (18295244)

Main Inventor

Yu-Hwa Lo


BIOMIMETIC LEAF WETNESS SENSOR AND METHOD OF MANUFACTURE OF THE SAME (18201886)

Main Inventor

Marco Rolandi


Tandem Activity-Based Sensing and Labeling Strategy for Reactive Oxygen Species Imaging (18363714)

Main Inventor

Christopher J. Chang


GPCR SCREENING METHOD TO IDENTIFY NON-HALLUCINOGENIC COMPOUNDS (18248934)

Main Inventor

Chunyang DONG


QUANTUM WRAPPER NETWORKING (18248931)

Main Inventor

Sung-Joo Ben Yoo

Retrieved from "http://wikipatents.org/index.php?title=The_Regents_of_the_University_of_California_patent_applications_published_on_November_30th,_2023&oldid=13285"